C225

N/A

Report date: 2025/09/25 20:00:07
NME

Base Information

Drug NameC225
Drug Alias NameC225
ClassificationOther
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsRectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesFudan University
China Registration ClassN/A

Develop Information

Active CompaniesFudan University
Inactive CompaniesN/A
Active IndicationsRectal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A